Tamsulosin Hydrochloride
Product Images NDC 71335-0711

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71335-0711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350711)

Label for Tamsulosin HCl 0.4 mg capsules by Bryant Ranch Prepack. The label indicates the capsules are green (olive green) and yellow (light yellow). It compares the product to Flomax 0.4 mg capsule from Sun Pharma Industries Ltd. The package contains 30 capsules and includes storage instructions and a barcode with associated NDC 71335-0711.*

FDA Label Image

Figure-1 (Tamsulosin Fig1)

A line graph showing plasma concentration (ng/mL) of a substance over time (hours) up to 36 hours. Two lines compare the substance's concentration under fasted and fed conditions, illustrating differences in absorption and plasma levels between these states.*

FDA Label Image

Figure-2a (Tamsulosin Fig2a)

A line graph depicting the mean change over weeks in a treatment study comparing Tamsulosin Hydrochloride 0.8 mg and 0.4 mg doses versus placebo. The x-axis represents duration of treatment in weeks from baseline to week 13 plus last observation carried forward (LOCF). The y-axis shows mean change, with lines for 0.8 mg, 0.4 mg, and placebo doses, illustrating decreasing mean change over time with treatment.*

FDA Label Image

Figure-2b (Tamsulosin Fig2b)

A line graph showing mean change over the duration of treatment in weeks for Tamsulosin Hydrochloride at doses of 0.8 mg and 0.4 mg compared to placebo. The x-axis represents weeks of treatment from 0 to 13 with an LOCF (last observation carried forward) measurement, and the y-axis shows mean change values. Data points for each treatment group are plotted with different symbols and lines, illustrating treatment effects over time.*

FDA Label Image

Tamsulosin-fig3a (Tamsulosin Fig3a)

A line graph showing mean change in mL/sec over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change from 0 to 3 mL/sec, and the x-axis shows treatment duration from baseline (B) to 13 weeks plus LOCF. The 0.8 mg and 0.4 mg treatment groups show higher mean changes compared to placebo over time.*

FDA Label Image

Tamsulosin-fig3b (Tamsulosin Fig3b)

A line graph depicting mean change in mL/sec over treatment duration in weeks for Tamsulosin Hydrochloride at doses of 0.8 mg and 0.4 mg compared to placebo. The x-axis shows treatment duration from 0 to 13 weeks plus LOCF, while the y-axis shows mean change from 0 to 3 mL/sec. Data points represent sample sizes at each time. Three lines track mean change for 0.8 mg dose (circles), 0.4 mg dose (triangles), and placebo (squares).*

FDA Label Image

Chemical-structure (Tamsulosin Str)

Chemical structure of the active ingredient Tamsulosin Hydrochloride as shown in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.